Conditional Cancer-Specific Survival for Inflammatory Breast Cancer: Analysis of SEER, 2010 to 2016.
- Published in:
- Clinical Breast Cancer, 2023, v. 23, n. 6, p. 628, doi. 10.1016/j.clbc.2023.05.005
- By:
- Publication type:
- Article
Works matching IS 15268209 AND DT 2023 AND VI 23 AND IP 6
Results: 11
1
2
Impact of Beta Blockers on Breast Cancer Incidence and Prognosis.
- Published in:
- Clinical Breast Cancer, 2023, v. 23, n. 6, p. 664, doi. 10.1016/j.clbc.2023.05.014
- By:
- Publication type:
- Article
3
Effect of Concurrent Proton Pump Inhibitors With Palbociclib Tablets for Metastatic Breast Cancer.
- Published in:
- Clinical Breast Cancer, 2023, v. 23, n. 6, p. 658, doi. 10.1016/j.clbc.2023.05.009
- By:
- Publication type:
- Article
4
Active Surveillance of Atypical Ductal Hyperplasia of the Breast.
- Published in:
- Clinical Breast Cancer, 2023, v. 23, n. 6, p. 649, doi. 10.1016/j.clbc.2023.05.008
- By:
- Publication type:
- Article
5
A Multicenter, Randomized, Controlled Study of the Breast Biopsy and Circumferential Excision System for Breast Lesions.
- Published in:
- Clinical Breast Cancer, 2023, v. 23, n. 6, p. 640, doi. 10.1016/j.clbc.2023.05.007
- By:
- Publication type:
- Article
6
Sentinel Node Biopsy in Patients With Breast Carcinoma Without Axillary Involvement at Diagnosis Receiving Primary Systemic Therapy.
- Published in:
- Clinical Breast Cancer, 2023, v. 23, n. 6, p. 672, doi. 10.1016/j.clbc.2023.05.018
- By:
- Publication type:
- Article
7
Serum lncRNA LINC01535 as Biomarker of Diagnosis, Prognosis, and Disease Progression in Breast Cancer.
- Published in:
- Clinical Breast Cancer, 2023, v. 23, n. 6, p. 620, doi. 10.1016/j.clbc.2023.05.004
- By:
- Publication type:
- Article
8
Factors Associated With Guideline-Concordant Pharmacological Treatment for Neuropathic Pain Among Breast Cancer Survivors.
- Published in:
- Clinical Breast Cancer, 2023, v. 23, n. 6, p. 598, doi. 10.1016/j.clbc.2023.05.002
- By:
- Publication type:
- Article
9
Race and Ethnicity Reporting and Enrollment Disparities in Clinical Trials Leading to FDA Approvals for Breast Cancer Between 2010 and 2020.
- Published in:
- Clinical Breast Cancer, 2023, v. 23, n. 6, p. 591, doi. 10.1016/j.clbc.2023.05.001
- By:
- Publication type:
- Article
10
Feasibility of Aerobic Exercise Training to Mitigate Cardiotoxicity of Breast Cancer Therapy: A Systematic Review and Meta-Analysis.
- Published in:
- Clinical Breast Cancer, 2023, v. 23, n. 6, p. 576, doi. 10.1016/j.clbc.2023.04.010
- By:
- Publication type:
- Article
11
The Effect of HER2-Low Status on Pathological Complete Response and Survival in Triple-Negative Breast Cancer: A Systemic Review and Meta-Analysis.
- Published in:
- Clinical Breast Cancer, 2023, v. 23, n. 6, p. 567, doi. 10.1016/j.clbc.2023.05.015
- By:
- Publication type:
- Article